Latest Market News

Raiz Invest has hit a record $2 billion in funds under management, driven by strong customer growth and innovative product launches. The fintech’s latest quarter also saw strategic partnerships expand its market reach.

Asian Battery Metals PLC has successfully raised $6 million through an oversubscribed equity placement, positioning the company to advance exploration and acquisition efforts across its Mongolian battery metals projects.

True North Copper has appointed Andrew Mooney as Managing Director, signaling a strategic shift towards advanced exploration and project development in Queensland.

Horizon Minerals reported steady gold production from Boorara and Phillips Find, unveiled promising high-grade drilling results at Burbanks, and acquired the Gordons Project near Black Swan, while progressing a key Pre-Feasibility Study for a gold processing plant conversion.

AdAlta Limited has raised up to A$1.1 million through a private placement, boosting its war chest to advance innovative cellular immunotherapy projects targeting solid cancers.

Love Group Global Ltd reports a modest rise in quarterly cash receipts and operating cash flow, driven by a rebound in Hong Kong, while Singapore lags. The company signals early moves toward US and UK expansion.

Neuren Pharmaceuticals has secured FDA Fast Track designation for its drug NNZ-2591 targeting Phelan-McDermid syndrome, accelerating its path through clinical development. This milestone underscores the urgent need for treatments in rare neurodevelopmental disorders.

Horizon Gold advances its Gum Creek project with significant gold intercepts from water bore drilling and launches an AI-powered exploration platform, while maintaining its feasibility study timeline and securing $12 million in fresh capital.

EPX Limited reported a net increase in Annual Contract Value to $18 million and a steady rise in Annual Recurring Revenue to $15.7 million for Q3 2025, driven by new contracts in the UAE healthcare sector and Australian commercial properties.

Bapcor reports a 2.7% revenue decline in 1Q26 and outlines a comprehensive operational review and cost-saving plan, setting cautious guidance for FY26.

Metal Powder Works Limited (MPW) has landed a $1 million contract with the US Navy for its innovative expeditionary DirectPowder™ unit, while expanding its alloy portfolio and customer base amid a $15 million capital raise.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.